Zoetis Wins 2024 Catalyst Award

Zoetis Inc. has been selected as a 2024 Catalyst Award recipient for its global initiative, Awareness and Action Drives Impact, that is advancing equity for women and other underrepresented groups across the company — from the frontlines to senior leadership. Zoetis is one of only two organizations receiving this global award and is the first animal health company to be recognized.

“We are truly honored to receive the 2024 Catalyst Award for our global DE&I initiatives,” said Kristin Peck, CEO of Zoetis. “At Zoetis, we embrace differences through intentional efforts that drive equity and belonging. Our DE&I efforts will only continue as we keep building a welcoming workplace and animal health industry that celebrates uniqueness – and enables us to make a positive impact on the lives of our colleagues and those who care for animals.”

Highlights that Catalyst featured as part of Zoetis’ recognition include:

  • “Global culture, regional customization: Zoetis’ Core Beliefs and global focus on inclusion serve as guiding principles for fostering a sense of belonging and expanding opportunities across the globe. At the same time, the company makes specific efforts to address the unique needs of different regions.”
  • “Frontline colleague inclusion: Women hold key leadership roles across Zoetis’ two primary frontline functions of manufacturing and sales, and career ladders and paths are available to all frontline colleagues. Everyone has access to an individualized development plan and support, and an understanding of how to advance, as well as opportunities to work on different projects or roles.”
  • “Colleague Resource Groups (CRGs) are an important catalyst to foster a diverse, inclusive environment at Zoetis, while positively impacting the company’s business and community. The CRGs bring together colleagues who share similar backgrounds, experiences and interests to work toward common goals that align with Zoetis’ strategic business priorities. CRGs also play a tremendous role in helping leadership understand the obstacles that different groups face, while promoting allyship and generating ideas for solutions.”
  • “Talent processes, both external-facing and internal-facing, have a powerful impact on representation and inclusion at Zoetis. External-facing processes include partnerships with INROADS and MANRRS to share the value of careers in animal health and increase the pool of underrepresented talent. Internal-facing processes include strong, intentional succession planning and access to sponsors, mentors, and leadership development opportunities.”

As a result of Zoetis’ global initiative, between 2020-2023 women’s global representation increased from 47% to 50% among senior and mid-level colleagues, and 44% to 49% (5 percentage points) in other levels of the organization, including frontline colleagues in manufacturing and sales. On the Board of Directors, women’s overall representation increased from 36% to 42% (6 percentage points), and the representation of women from marginalized racial and ethnic groups increased from 9% to 17% (8 percentage points).

Zoetis participated in a rigorous examination by Catalyst of the company’s talent, diversity, equity and inclusion initiatives requiring the company to show proven, measurable results that benefit women across a range of dimensions. This was followed by intensive on-site interviews to hear directly from colleagues about their experiences at Zoetis as a result of the multi-year, multi-faceted global initiative.

Zoetis will be honored at the Catalyst Awards Conference & Gala on Tuesday, March 12, in New York City. This year’s theme, The Catalyst Effect, celebrates the collective impact of individuals committed to diversity, equity, and inclusion — who together can create massive change.


  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

WVC Annual Conference 2024


Diagnostic accuracy of plain radiography to identify synovial penetration in horses with traumatic limb wounds


Effects of administration of vitamin C on oxidative status in healthy horses


Viticus Group 96th WVC Annual Conference is Back – It’s Time to Vet Differently


Exocrine pancreatic insufficiency in dogs and cats




News of interest


Copyright © 2024 - All Rights Reserved
ISSN 2768-198X